Allogene Therapeutics Inc. logo

Allogene Therapeutics Inc.

ALLO | NASDAQ
Chart Builder DCF Calculator
$1.71
+$0.02 (+1.18%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
51.69M 75.22M 83.16M 61.9M 173.31M 183.35M
Short-Term Investments
198.52M 217.26M 365.54M 455.42M 283.99M 644.56M
Long-Term Investments
8.04M 80.67M 3.65M 76.47M 382.38M 207.95M
Other Long-Term Assets
37.39M 33.39M 16.9M 19.86M 16.11M 14.62M
Receivables
1.5M 1.9M 1.7M n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
6.04M 9.01M n/a 11.5M n/a n/a
Total Current Assets
257.75M 303.39M 459.12M 528.82M 471.32M 845.13M
Property-Plant & Equipment
112.73M 131.26M 163.18M 196.43M 181.02M 160.14M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
158.16M 245.32M 183.72M 292.76M 579.51M 382.7M
Total Assets
415.91M 548.71M 642.84M 821.58M 1.05B 1.23B
Account Payables
4.27M 5.39M 5.9M 13.89M 10.26M 10.39M
Deferred Revenue
n/a n/a 86K 95K 156K 38.99M
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
10.24M 12.15M 11.66M 17.94M 16.13M 12.97M
Total Current Liabilities
32.51M 35.52M 37.08M 53.73M 47.91M 94.32M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
15.8M 7.76M 5.18M 5.85M 7.79M 3.08M
Total Long-Term Liabilities
90.85M 91.01M 93.53M 100.97M 77.72M 53.89M
Total Liabilities
123.36M 126.53M 130.6M 154.7M 125.63M 148.21M
Total Debt
83.25M 90.76M 95.12M 101.12M 73.13M 53.78M
Book Value
292.54M 422.18M 512.23M 666.88M 925.2M 1.08B
Book Value Per Share
1.33 2.17 3.26 4.66 6.81 8.97
Common Stock
229K 212K 169K 144K 142K 140K
Retained Earnings
-2.01B -1.82B -1.56B -1.23B -894.55M -646.34M
Comprehensive Income
269K -89K -955K -9.93M -2.57M 268K
Shareholders Equity
292.54M 422.18M 512.23M 666.88M 925.2M 1.08B
Total Investments
206.57M 297.93M 369.19M 531.88M 666.37M 852.51M

© 2026 bestshares.com. All rights reserved.